Table 2 Univariate analysis of DFS and OS for The Whole Group
Variable | Number of patients | 5-year DFS | P value | 5-year OS | P value |
|---|---|---|---|---|---|
Age, year | 0.063 | 0.044 | |||
≥ 49 | 20 | 15.0% | 25.0% | ||
< 49 | 23 | 39.1% | 50.6% | ||
FIGO Stage | 0.352 | 0.414 | |||
I | 25 | 28.0% | 34.3% | ||
II | 18 | 27.8% | 44.4% | ||
Tumor biology | 0.398 | 0.554 | |||
pure | 31 | 25.8% | 38.7% | ||
mixed | 12 | 33.3% | 38.9% | ||
Lymph node metastasis | 0.003 | 0.035 | |||
yes | 19 | 10.5% | 31.6% | ||
no | 24 | 41.7% | 44.9% | ||
Adjuvant radiation | 0.038 | 0.097 | |||
yes | 28 | 35.7% | 42.9% | ||
no | 15 | 13.3% | 31.1% | ||
Tumor size, cm | 0.342 | 0.116 | |||
≥ 4 | 23 | 26.1% | 30.4% | ||
< 4 | 20 | 30.0% | 48.7% | ||
LVSI | 0.388 | 0.209 | |||
yes | 23 | 26.1% | 33.8% | ||
no | 20 | 30.0% | 45.0% |